Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Judy Kovacs"'
Autor:
Fatimah Al-Ani, Sarah Weisz, Martha L Louzada, Camilla Rozanski, Judy Kovacs, Alejandro Lazo-Langner, Michael J. Kovacs
Publikováno v:
Thrombosis research. 167
Background Optimal prophylactic strategies in pregnant women with a history of venous thromboembolism (VTE) are unknown. Patients and methods We conducted a retrospective cohort study of consecutive pregnant patients with a previous VTE history. Pati
Publikováno v:
Clinical and Laboratory Haematology. 28:9-13
Summary In the 50% of cases of acute idiopathic venous thromboembolism, laboratory testing for inherited causes is often performed. Most physicians are under the impression that assays for protein C and protein S should not be measured at the time of
Autor:
Marc Carrier, Marc A. Rodger, David Anderson, Michael J. Kovacs, Annmarie Bosco, Roweena Corpuz, Judy Kovacs, Alejandro Lazo-Langner, Susan R. Kahn, Philip S. Wells
Publikováno v:
Blood. 128:417-417
Introduction. Upper extremity deep vein thrombosis (UEDVT) is a relatively uncommon event with potentially serious complications. Its clinical outcomes are not well studied. The objective of this study was to assess the incidence of post-thrombotic s
Autor:
Nancy Carson, Marc A. Rodger, Grégoire Le Gal, Philip S. Wells, Susan Solymoss, Marc Carrier, Tim Ramsay, Isabelle Chagnon, David A. Anderson, Mark Crowther, Susan R. Kahn, Nicole Langlois, Esteban Gandara, Julian Little Ma, Michael J. Kovacs, Judy Kovacs
Publikováno v:
Thrombosis and Haemostasis
Thrombosis and Haemostasis, Schattauer, 2013, 110 (6), pp.1172-9. ⟨10.1160/TH13-06-0488⟩
Thrombosis and Haemostasis, Schattauer, 2013, 110 (6), pp.1172-9. ⟨10.1160/TH13-06-0488⟩
SummaryThe role of ABO blood type as a risk factor for recurrent venous thromboembolism (VTE) in patients with a first unprovoked VTE who complete oral anticoagulation therapy is unknown. The aim of this study was to determine if non-OO blood type is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f49af22b07d235c98db7ef020d1c531
https://hal.univ-brest.fr/hal-00934053
https://hal.univ-brest.fr/hal-00934053
Autor:
CA Hoefnagel, B StJacques, Jareer Kassis, Krystyna Kinnon, Terri Finch, M Berger, E Ascari, F. Turkstra, J Stanford, M Escribano, Mmw Koopman, Judy Kovacs, D ElKouri, Agg Turpie, J vanderMeer, Antonio Girolami, Eki Code, PM Manucci, Beverly Morrow, Paolo Bucciarelli, A vanBarneveld, Susan Haley, Sergio Siragusa, Paul Ockelford, Manuel Monreal, G Garrido, P Nguyen, Marco Moia, D Cohlan, S Bornais, D. P. M. Brandjes, M Barone, B Girolami, Dianne Donovan, Sabina Villalta, S Roy, E Lafoz, Ejr vanBeek, S Serafini, Judith Johnson, L Biagioni, B Petiteau, Patrick Brill-Edwards, L Rossi, Beng H. Chong, L Wilkinson, MA Pistorius, Jeffrey S. Ginsberg, B Planchon, P Bagatella, M vonLewinski, J Jagot, Sylvia Haas, Moira Cruickshank, YP Graafsma, R. Baildon, Michael Gent, Awa Lensing, J. I. Weitz, Christine Demers, JN Fiesinger, Richard M. Jay, Alexander Gallus, William Geerts, Gth Que, S Finkenbine, Clive Kearon, C N Chesterman, Eleanor Boyle, L Couture, L LIberale, Anderson, LT Eimers, C Rich, G Simonneau, F Parent, WM Smid, Pmm Kuijer, B Palmer, R Faivre, J CoteDesjardins, KS Robinson, F Lossner, WM Brien, K Redekop, [No Value] Cusson, M deRijk, Paolo Prandoni, T Bynon, James D. Douketis, D Goudie, Janis Bormanis, [No Value] Leclerc, Louis Desjardins, C Beltrametti, JW tenCate, H Jagt, Martin H. Prins, Michael J. Kovacs, FA Spengel, S Whittaker, M Ruel, H. R. Büller, P. S. Wells, Franco Piovella, Jack Hirsh, John Cade, Barbara A. Hutten, J Poulin, JC Sahuquillo, J Villenueve, Jgp Tijssen, Rohan J. K. Hettiarachchi, S Pritchard
Publikováno v:
ResearcherID
New England journal of medicine, 337(10), 657-662. Massachussetts Medical Society
New England Journal of Medicine, 337(10), 657-662. MASSACHUSETTS MEDICAL SOC
New England journal of medicine, 337(10), 657-662. Massachussetts Medical Society
New England Journal of Medicine, 337(10), 657-662. MASSACHUSETTS MEDICAL SOC
Background Low-molecular-weight heparin is known to be safe and effective for the initial Treatment of patients with proximal deep-vein thrombosis. However, its application to patients with pulmonary embolism or previous episodes of thromboembolism h
Autor:
David Anderson, Marc Carrier, Marc A. Rodger, Annmarie Bosco, Judy Kovacs, Alejandro Lazo-Langner, Michael J. Kovacs, Roweena Corpuz, Susan R. Kahn, Philip S. Wells
Publikováno v:
Blood. 126:893-893
Introduction . Upper extremity deep vein thrombosis (UEDVT) is a relatively uncommon event with potentially serious complications. Its optimal treatment and clinical outcomes are not well studied. The objective of our study was to assess the safety a
Autor:
Peggy Florack, Donna Touchie, Beverly Morrow, Michael J. Kovacs, Melissa A. Forgie, Philip S. Wells, David Anderson, Marc A. Rodger, George A. Wells, Judy Kovacs, Keith O'Rourke, Lisa Gray
Publikováno v:
Archives of internal medicine. 165(7)
Background: Low-molecular-weight heparins (LMWHs) are now standard therapy for the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE). No published trials have compared LMWHs, and few studies have examined outpatient therapy for PE.
Autor:
Michael J. Kovacs, Melissa A. Forgie, Bev Morrow, Janis Bormanis, Philip S. Wells, Donna Goudie, Judy Kovacs
Publikováno v:
Archives of internal medicine. 158(16)
Background: The outpatient treatment of patients with deep vein thrombosis and pulmonary embolism using lowmolecular-weight heparin has the potential to reduce health care costs, but it is unclear if most patients with deep vein thrombosis and pulmon
Autor:
Melinda Robbins, Michael J. Kovacs, Bev Morrow, Alejandro Lazo-Langner, Leonard Minuk, Judy Kovacs
Publikováno v:
Thrombosis Journal
Department of Medicine Publications
Thrombosis Journal, Vol 8, Iss 1, p 10 (2010)
Department of Medicine Publications
Thrombosis Journal, Vol 8, Iss 1, p 10 (2010)
Background Protein C (PC) and protein S (PS) determination is part of the thrombophilia investigation in patients with idiopathic venous thromboembolism (VTE). Based on scarce evidence it is a common notion that PC and PS levels decrease during the a
Autor:
Judy Kovacs, Michael J. Kovacs, Eleanor Boyle, P. S. Wells, H Kim, I Chinyee, Beverly Morrow, Moira Cruickshank
Publikováno v:
ResearcherID
Scopus-Elsevier
Scopus-Elsevier
Standard treatment for venous thromboembolism is parenteral heparin followed by warfarin. In this study we assess whether a standardized method of ordering warfarin reduces the duration of hospitalization. Consecutive patients were randomized to rece
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8553bf54d45afdb0d778876a37bf2be5
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000079503400002&KeyUID=WOS:000079503400002
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000079503400002&KeyUID=WOS:000079503400002